

Dopamine(DOPE) Price Live Chart
Dopamine(DOPE) price today is $0.001156, with a 24-hour trading volume of $89.85K and as such Dopamine(DOPE) has a market cap of $31.45K, giving it a market dominance of 0.0000042%. The Dopamine(DOPE) price moved -10.49% in the last 24 hours.
DOPE Price Data
- 24H Volume$89.85K
- All-Time High(ATH)$0.6559
- 24h High$0.001286
- All-Time Low(ATL)$0.0005
- 24h Low$0.00115
DOPE Market Cap Infos
- Market Cap$31.45K
- Fully Diluted Valuation$144.52K
- Market Cap/FDV21.77%
- Market SentimentPositive
DOPE Supply
- Circulating Supply27.2M DOPE
- Total Supply125M DOPE
- Max Supply125M DOPE
Dopamine(DOPE) is predicted to average $0.00125 in 2025, with a potential swing between the lowest price $0.000925 and the highest price $0.00145. By 2035, Dopamine(DOPE) price could reach to $0.004396, offering a potential +248.00% return from today’s Dopamine price.
Year | Minimum Price | Highest Price | Average Price | Change |
---|---|---|---|---|
2025 | $0.000925 | $0.00145 | $0.00125 | +8.00% |
2026 | $0.000891 | $0.001633 | $0.00135 | +16.00% |
2027 | $0.0008652 | $0.001551 | $0.001491 | +29.00% |
2028 | $0.001004 | $0.002115 | $0.001521 | +31.00% |
2029 | $0.001036 | $0.002618 | $0.001818 | +57.00% |
2030 | $0.001464 | $0.003216 | $0.002218 | +91.00% |
2031 | $0.00201 | $0.003369 | $0.002717 | +135.00% |
2032 | $0.001917 | $0.003439 | $0.003043 | +163.00% |
2033 | $0.003144 | $0.003565 | $0.003241 | +180.00% |
2034 | $0.002178 | $0.004662 | $0.003403 | +194.00% |
2035 | $0.00254 | $0.004396 | $0.004033 | +248.00% |
Dopamine(DOPE) price has moved -10.49% in the last 24 hours, and +2.41% in the past 7 days. The price of Dopamine(DOPE) is -38.69% in the past 30 days, and -95.57%over the last year.
Time period | Change amount | % Change |
---|---|---|
1H | -$0.0000277 | -2.34% |
24H | -$0.0001354 | -10.49% |
7D | +$0.0000272 | +2.41% |
30D | -$0.0007296 | -38.69% |
1Y | -$0.02494 | -95.57% |
About Dopamine (DOPE)
Contract

8kqmghm1m...d3eanwkcd
Explorers
explorer.solana.com
Website
web3intelligence.com
Dopamine (DOPE) Investors


